PATHOLOGIC EFFECTS OF ELIXIR OF SULFANILAMIDE (DIETHYLENE GLYCOL) POISONING: A CLINICAL AND EXPERIMENTAL CORRELATION: FINAL REPORT

ABSTRACT

During the months of September and October 1937 at least seventy-six1 human beings in various localities died as a result of poisoning by Elixir of Sulfanilamide-Massengill.2 By analysis,3 the A. M. A. Chemical Laboratory found this preparation to be essentially a 10 per cent solution of sulfanilamide in about 72 per cent diethylene glycol, together with some coloring and flavoring agents. There were no contaminants such as mercury, the effects of which might have resembled the clinical symptoms produced by the elixir. Apparently the makers of this product were unaware of its possible toxicity and distributed it freely without having tested it adequately on animals. It had not been submitted to the Council on Pharmacy and Chemistry of the American Medical Association nor did the Food and Drug Administration of the United States Department of Agriculture know of its composition. Newspaper reports of deaths from this "new

First Page Preview

Figures

Tables

References

Letters

The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with
the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.

This feature is provided as a courtesy. By using it you agree that that you are requesting the material solely for personal, non-commercial use, and that it is subject to the AMA's Terms of Use. The information provided in order to email this article will not be shared, sold, traded, exchanged, or rented. Please refer to The JAMA Network's Privacy Policy for additional information.

Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.